Today's Analyst Rating | Berkshire Hathaway-B Price Target Raised to $606 by UBS, Wells Fargo Cuts Its Price Target Cut on Chevron to $164
Morgan Stanley Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Cuts Target Price to $958
TD Cowen Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $800
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today
Why Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday?
Guggenheim Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Cuts Target Price to $810
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
skumaar42 : Great info!